Sandoz Says Bayer's Xarelto Patent Is Overbroad
Novartis unit Sandoz is suing rival drugmaker Bayer, claiming that a patent protecting the German pharma company's blockbuster blood-thinning drug Xarelto should not cover all thromboembolic disorders....To view the full article, register now.
Already a subscriber? Click here to view full article